Results 101 to 110 of about 158,039 (202)

Significant Clinical Improvements Following Arthroscopic Iliopsoas Fractional Lengthening After Total Hip Arthroplasty: A Prospective Multicenter Study

Arthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To prospectively investigate subjective anterior groin pain, patient‐reported outcome measures, complications, reoperation rates, and hip flexion strength after arthroscopic iliopsoas fractional lengthening. Methods From 2023 to 2025, patients with persistent groin pain after total hip arthroplasty refractory to conservative management ...
Brandon Cabarcas, Sanathan Iyer, Sandeep Yanamala, Jason Ina, Alexander Bishop, Adam V. Daniel, Bruce A. Levy, Mario Hevesi   +7 more
wiley   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

Speckle Observations With PISCO in Calern (France): III. Astrometric Measurements of Visual Double Stars in 2019 and New or Revised Orbits for STT531 AB, STT77 AB, STF1338 AB, COU1746, STT260, A1109 AB, HU1291, and A632 AB

Astronomische Nachrichten, EarlyView.
ABSTRACT We present relative astrometric measurements of visual double stars, made in 2019 with the speckle camera PISCO at the 1‐m Epsilon telescope of the C2PU facility (Observatoire de la Côte d'Azur, Calern site). Our observing list contains orbital couples as well as double stars whose motion is still uncertain.
J.‐L. Prieur, M. Scardia, J.‐P. Rivet, E. Aristidi, J. F. Ling, L. Piccotti, L. Pansecchi, R. W. Argyle, L. Abe, P. Bendjoya, L. Maccarini, D. Vernet   +11 more
wiley   +1 more source

Vamorolone Safety, Pharmacokinetics, and Exploratory Efficacy in Duchenne Muscular Dystrophy: A Phase II, Nonrandomized, Multiple-Dose Study in 2-<4-Year-Old Boys. [PDF]

Neurology
Mah JK, Gonorazky HD, Nigro E, Lochmüller H, Alemán A, Yaworski A, Oskoui M, Sbrocchi AM, Selby KA, de Vera A, Mathur R, Gresko E, Linden A, Dutreix C, Hoffman EP.   +14 more
europepmc   +1 more source

NiFe‐NO3 Layered Double Hydroxide as a Novel Anode for Sodium Ion Batteries

Batteries &Supercaps, Volume 8, Issue 3, March 2025.
This study demonstrates, for the first time, the effectiveness of using LDH as an anodic material in SIB. The material is stable and show high specific capacity, the reaction mechanism has been thoroughly investigated and comprehensively described and involves a phase change reaction followed by sodium intercalation.
Marco Fortunato, Angelina Sarapulova, Björn Schwarz, Anna Maria Cardinale, Sonia Dsoke   +4 more
wiley   +1 more source

A Unified Mass Spectrometry Workflow Integrating Bottom-Up and Native Top-Down Proteomics via Nanodroplet Enzymatic Digestion. [PDF]

Anal Chem
Wang HW, Hong YL, Chiang TY, Lai SH.
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Estimated efficacy of the adjuvanted RSVPreF3 vaccine against diverse and worldwide predominant RSV strains, irrespective of RSV F protein variation: results of a post-hoc analysis from the AReSVi-006 trial. [PDF]

EBioMedicine
De Smedt J, Gruselle O, Sacconnay L, Baup D, Lambert C, Xavier S, Crudele F, Olivier A, Vanloubbeeck Y, Van der Wielen M, David MP, Dezutter N, Warter L.   +12 more
europepmc   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

A phosphorous-based dendrimer targets mitochondria and normalizes the keratinocyte proliferation/differentiation balance to improve psoriasis. [PDF]

PLoS One
Clement E, Jebbawi R, Oukhrib A, Labie H, Le Moal M, Fruchon S, Cassel S, Caminade AM, Turrin CO, Blanzat M, Simon M, Poupot R.   +11 more
europepmc   +1 more source